These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22727627)

  • 1. Post-discharge clinical and angiographic outcomes of patients presenting within 48h of STEMI treated with paclitaxel- or sirolimus-eluting stents.
    Ishikawa T; Mutoh M; Nakano Y; Suzuki T; Nakata K; Murakami A; Miyamoto T; Yoshimura M
    J Cardiol; 2012 Sep; 60(3):174-9. PubMed ID: 22727627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-month angiographic and one-year clinical outcomes of polymer free paclitaxel-eluting stent in patients with ST-segment elevation myocardial infarction: a comparison with permanent polymer sirolimus-eluting stent.
    Dang Q; Li YJ; Gao L; Jin Z; Gou LX
    Chin Med J (Engl); 2012 Oct; 125(19):3393-7. PubMed ID: 23044294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans.
    Suh JW; Park JS; Cho HJ; Kim MS; Kang HJ; Cho YS; Koo BK; Chung WY; Youn TJ; Chae IH; Choi DJ; Kim HS; Sohn DW; Oh BH; Park YB
    Int J Cardiol; 2007 Apr; 117(1):31-6. PubMed ID: 17292498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial.
    Kang WC; Ahn T; Lee K; Han SH; Shin EK; Jeong MH; Yoon JH; Park JS; Bae JH; Hur SH; Rha SW; Oh SK; Kim DI; Jang Y; Choi JW; Kim BO
    EuroIntervention; 2011 Dec; 7(8):936-43. PubMed ID: 21959255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
    J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective comparison of clinical and angiographic outcomes after primary stenting using sirolimus-eluting and bare-metal stents in nonrandomized consecutive 568 patients with first ST-segment elevated myocardial infarctions.
    Ishikawa T; Mutoh M; Nakano Y; Endo A; Kubota T; Suzuki T; Nakata K; Murakami A; Miyamoto T; Sakamoto H; Okada H; Imai K; Yoshimura M
    J Cardiol; 2011 Jan; 57(1):44-52. PubMed ID: 21146366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
    Daemen J; Tanimoto S; García-García HM; Kukreja N; van de Sande M; Sianos G; de Jaegere PP; van Domburg RT; Serruys PW
    Am J Cardiol; 2007 Apr; 99(8):1027-32. PubMed ID: 17437722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
    Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
    Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity score matched lesion-based comparison of long-term clinical and angiographic outcomes after placement of sirolimus (Cypher Bx Velocity) and paclitaxel (TAXUS Express)-eluting stents for de novo native coronary stenosis.
    Nakano Y; Ishikawa T; Hino S; Mutoh M
    Cardiovasc Interv Ther; 2014 Apr; 29(2):93-101. PubMed ID: 24122399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
    Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice.
    Cosgrave J; Melzi G; Corbett S; Biondi-Zoccai GG; Agostoni P; Babic R; Airoldi F; Chieffo A; Sangiorgi GM; Montorfano M; Michev I; Carlino M; Colombo A
    J Am Coll Cardiol; 2007 Jun; 49(24):2320-8. PubMed ID: 17572247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year clinical and six month angiographic results of drug eluting stents for ST elevation acute myocardial infarction: 'real world' comparison between sirolimus- and paclitaxel-eluting stents.
    Park KW; Cho YS; Chung JW; Yeon TJ; Chae IH; Choi DJ; Oh BH; Park YB; Chung WY
    Int J Cardiol; 2009 Jan; 131(3):350-5. PubMed ID: 18180056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
    Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
    J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus- versus paclitaxel-eluting stents for coronary bifurcations intervention: a meta-analysis of five clinical trials.
    Qian J; Chen Z; Ma J; Ge J
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):507-13. PubMed ID: 22045690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries.
    Tanimoto S; Daemen J; Tsuchida K; García-García HM; de Jaegere P; van Domburg RT; Serruys PW
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):94-103. PubMed ID: 17139687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital and mid-term clinical outcomes after percutaneous coronary intervention with the use of sirolimus- or paclitaxel-eluting stents.
    Alidoosti M; Salarifar M; Kassaian SE; Zeinali AM; Nematipoor E; Sheikhfathollahi M; Poorhosseini H; Dehkordi MR; Abbasi A
    Kardiol Pol; 2009 Dec; 67(12):1344-50. PubMed ID: 20054765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective comparison of midterm clinical and angiographic outcomes after the implantation of paclitaxel- and sirolimus-eluting stents for de novo coronary complex lesions in nonrandomized Japanese patients.
    Ishikawa T; Nakano Y; Mutoh M
    Intern Med; 2012; 51(19):2695-701. PubMed ID: 23037458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 5-year clinical outcomes between sirolimus-versus paclitaxel-eluting stent: Korean multicenter network analysis of 9000-patient cohort.
    Park K; Park KW; Rha SW; Bae JH; Hur SH; Park JS; Yoon JH; Jang Y; Jeong MH; Kim HS
    Circ Cardiovasc Interv; 2012 Apr; 5(2):174-84. PubMed ID: 22396583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.